Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Shares Outstanding (2023 - 2025)

Inhibrx Biosciences (INBX) has disclosed Shares Outstanding for 3 consecutive years, with $14.6 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 0.7% to $14.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $14.6 million through Dec 2025, up 0.7% year-over-year, with the annual reading at $14.6 million for FY2025, 0.7% up from the prior year.
  • Shares Outstanding for Q4 2025 was $14.6 million at Inhibrx Biosciences, up from $14.5 million in the prior quarter.
  • The five-year high for Shares Outstanding was $49.2 million in Q1 2024, with the low at $14.5 million in Q4 2024.
  • Average Shares Outstanding over 3 years is $26.3 million, with a median of $14.5 million recorded in 2025.
  • Peak annual rise in Shares Outstanding hit 0.7% in 2025, while the deepest fall reached 70.6% in 2025.
  • Over 3 years, Shares Outstanding stood at $47.4 million in 2023, then crashed by 69.44% to $14.5 million in 2024, then rose by 0.7% to $14.6 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $14.6 million, $14.5 million, and $14.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.